Point72 (DIFC)’s Cellebrite CLBT Stock Holding History

Point72 (DIFC)’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29	Closed	-$461	–	1260
2025 Q2	$461	Buy	+29	New	+$517	﹤0.01%	1467

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Point72 (DIFC)'s CLBT Position: Q3 2025 in Review

Point72 (DIFC) sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 29 shares — an estimated $461 sold.

Point72 (DIFC) first reported a position in CLBT in Q2 2025 and held it in 1 quarter. The position peaked at $461 in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

Point72 (DIFC) reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
Point72 (DIFC) sold 29 Cellebrite shares in Q3 2025, an estimated $461.
Point72 (DIFC) first reported a position in Cellebrite in Q2 2025 and held it in 1 quarter.
Point72 (DIFC)'s Cellebrite position peaked at $461 in Q2 2025.
197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.